• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Japanese Hospital to initiate program with Asensus Surgical’s Senhance surgical robot

Japanese Hospital to initiate program with Asensus Surgical’s Senhance surgical robot

September 9, 2022 By Sean Whooley

Asensus Senhance Surgical Robot
[Image from Asensus Surgical]
Asensus Surgical (NYSE:ASXC) announced today that a hospital in Japan agreed to lease and utilize its Senhance surgical robot system.

Saiseikai Shiga Hospital in Ritto, Japan, agreed to a deal with Research Triangle Park, North Carolina-based Asensus.

The hospital will use the Asensus Senhance surgical system. The first-of-its-kind digital laparoscopic surgical robot uses augmented intelligence to perform procedures through machine learning. It features surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization.

Asensus said in a news release that Senhance is the first platform to offer 3mm instruments. They are the smallest instrument available in the world on a robotic surgical platform.

“We are very excited to be partnering with Saiseikai Shiga Hospital, one of the leading hospitals in Japan. While the system will be initially utilized in the General Surgery Department, we look forward to assisting the hospital in expanding their Senhance program into additional departments and specializations,” said Anthony Fernando, Asensus Surgical president and CEO. “We continue to drive increased utilization of Senhance globally as surgeons continue to see the value associated with Senhance’s clinical intelligence and digital tools which have wide applicability across surgical specialties and types of procedures.”

Asensus Senhance: powered by augmented reality

Senhance is powered by Asensus’ Intelligent Surgical Unit (ISU). The ISU enables real-time surgical image analytics coupled with machine vision-driven control of the camera. It responds to commands and recognizes certain objects in the surgical field.

The ISU allows a surgeon to measure anatomy, place digital tags and enhance the surgical image. It offers augmented intelligence-drive control of the camera so the surgeon can focus on other critical tasks.

“We are very excited to incorporate the unique features of the Senhance System into our surgical offerings. Familiarity with laparoscopy, lower cost per procedure similar to laparoscopy and clinical intelligence capabilities combined with robotic precision and novel features make the platform a wonderful addition to our hospital,” said Dr. M. Masuyama, VP and head of the surgical department at Saiseikai Shiga Hospital. “As we focus on providing the highest level of care for our patients, the Senhance System will allow us to expand our robotic surgery department to help deliver better patient outcomes.”

Filed Under: Business/Financial News, Surgical, Surgical Robotics Tagged With: Asensus Surgical, surgical robot

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy